Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage
Some patients taking GLP-1 drugs for weight loss have been forced to switch to a different medication due to a change in insurance coverage — and they’re not happy about it. As of July 1, CVS Caremark — one of the biggest pharmacy benefit managers in the U.S. — dropped Zepbound (tirzepatide) from its preferred…

